Company news
Cipher Pharmaceuticals Inc. news in 2024
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2024, newest first.
Cipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data in MOB-015 Phase 3 Study
December 10, 2024
Cipher Pharmaceuticals Reports Third Quarter 2024 Results
November 7, 2024
Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call
November 4, 2024
Cipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer
October 8, 2024
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
September 24, 2024
Cipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study
September 13, 2024
Cipher Pharmaceuticals Reports Second Quarter 2024 Results
August 8, 2024
Cipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference Call
August 1, 2024
Cipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million
July 29, 2024
Cipher Pharmaceuticals Reports First Quarter 2024 Results
May 9, 2024
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call
May 3, 2024
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 3, 2024
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
March 8, 2024
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading
January 29, 2024